Creating 3D modular tissues to guide stem cells
Constructing 3D voxelated tissues with molecular architecture encoded modular biomaterials to understand and control stem cell function
Researchers are building tiny 3D tissue-like building blocks to guide how stem cells grow and act, which could help people who need tissue repair or replacement.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-11145746 on NIH RePORTER |
What this research studies
From a patient's perspective, the team will design new biomaterials that mimic the molecular and mechanical features of real tissues and assemble them into small 3D 'voxels' or building blocks. They'll put stem cells into these voxelated materials and observe how changes in polymer architecture and time-dependent mechanics influence cell behavior and organization. This lab-based work aims to reveal how to control stem cell function and to create engineered tissues that more closely match natural organs. Over time, those insights could guide development of improved regenerative treatments.
Who could benefit from this research
Good fit: People most likely to benefit in the future are those needing tissue repair or replacement, such as patients with severe wounds, joint damage, or organ injury.
Not a fit: Patients with conditions unrelated to tissue damage or systemic diseases that cannot be treated by local tissue engineering are unlikely to benefit directly from this project.
Why it matters
Potential benefit: If successful, this work could lead to better engineered tissues and improved stem-cell therapies for repairing damaged organs, bones, cartilage, or skin.
How similar studies have performed: Related biomaterials and 3D tissue-engineering approaches have shown promising preclinical results, but building tightly organized voxelated tissues with encoded molecular architecture is a novel and less-tested approach.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Cai, Liheng — University of Virginia
- Study coordinator: Cai, Liheng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.